RenatoMariaSantosMD

Cardiology • Winston Salem, NC

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Preventive Cardiology, Vascular Medicine

Emory Heart and Vascular Center at Johns Creek

Join to view full profile

Dr. Santos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Santos' full profile

Already have an account?

Office
S Hawthorne Rd
Winston Salem, NC 27157
Phone+1 336-716-2255

Summary

Dr. Renato Santos is a cardiologist in Johns Creek, GA and is affiliated with multiple hospitals in the area, including Emory Johns Creek Hospital, Emory University Hospital, and Atlanta VA Medical Center. He received his medical degree from University of Iowa Carver College of Medicine and has been in practice 27 years. He specializes in interventional cardiology, peripheral endovascular interventional cardiology, preventive cardiology, and vascular medicine and is experienced in interventional cardiology, preventive cardiology, peripheral vascular disease, and peripheral endovascular interventional cardiology.

Clinical Expertise

Cardiac critical care, Peripheral endovascular interventional cardiology, Preventive cardiology

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1993 - 1997
Duke University HospitalResidency, Internal Medicine, 1990 - 1993
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1989
University of IowaB.A., Biochemistry, 1985

Certifications & Licensure

GA State Medical License 2015 - 2025
NC State Medical License 1994 - 2025
VA State Medical License 1994 - 2010
TN State Medical License 1998 - 2005
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Alpha Omega Alpha 1988
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Best Doctors in America 2011
Health Care Hero Award 2002
Melvin L. Marcus Clinical Research Award 1990
Clinical Research Award Iowa Student Medical Research Club, 1989
Alpha Omega Alpha University of Iowa, 1988
Bierring Porter Award, Achievement in Medical Microbiology 1986
Undergraduate Honors Program University of Iowa, 1981
Join now to see all

Publications & Presentations

PubMed

16 citations
Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention.
Robert J. Applegate, Matthew T. Sacrinty, Pascha Schafer, Justin W. Smith, Sanjay Gandhi
Catheterization and Cardiovascular Interventions. 2013-10-01
20 citations
Transitioning to the radial artery as the preferred access site for cardiac catheterization: An academic medical center experience†
Samuel J. Turner, Matthew T. Sacrinty, Michael R. Manogue, William C. Little, Sanjay Gandhi
Catheterization and Cardiovascular Interventions. 2012-08-01
22 citations
Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
Jason T. Call, Matthew T. Sacrinty, Robert J. Applegate, William C. Little, Renato M. Santos
The Journal of Invasive Cardiology. 2006-10-01

Journal Articles

Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention
Applegate RJ, Sacrinty MT, Schafer PE, Smith JW, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Little WC, Cathet Cardiovasc Interv, 1/1/2013
Transitioning to the radial artery as the preferred access site for cardiac catheterization: An academic medical center experience
Turner S, Sacrinty M, Monogue M, Little W, Gandhi S, Kutcher M, Santos R, ApplegateR, Catheter Cardiovasc Interv, 1/1/2012
Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice
Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ, Circ Cardiovasc Qual Outcomes, 1/1/2011
Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes
Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, J Invasive Cardiol, 1/1/2010
Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Circ Cardiovasc Interv, 1/1/2009
3-year comparison of drug-eluting stents versus bare metal stents
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, J Am Coll Cardiol Intv, 1/1/2009
Prognostic implications of vascular complications following PCI
Applegate RJ, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cath Cardiovasc Intervent, 1/1/2009
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC, Am Heart J, 1/1/2009
Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propensity score analysis
Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W, Catheter Cardiovasc Interv, 1/1/2008
"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC, J Am Coll Cardiol, 1/1/2008
Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007
Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC, J Am Coll Cardiol Intv, 1/1/2008
Incidence of coronary stent thrombosis based on academic research consortium definitions
Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA, Am J Cardiol, 1/1/2008
Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death
Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC, Am J Cardiol, 1/1/2007
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)
Echols MR, Mahaffey KW, Banerjee A, Pieper KS, Stebbins A, Lansky A, Cohen MG, Velazquez E, Santos R, Newby LK, Gurfinkel EP, Biasucci L, Ferguson JJ, Califf RM, Am J Cardiol, 1/1/2007
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial
Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV Jr, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JW, Eur Heart J, 1/1/2007
Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction
Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV Jr, Ohman EM, Gibler WB, Peterson ED, Am J Med, 1/1/2007
Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003
Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC, Catheter Cardiovasc Interv, 1/1/2006
Vascular complications with newer generations of Angioseal vascular closure devices
Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, Santos RM, Little WC, J Interv Cardiol, 1/1/2006
Renal artery stenting: characteristics and outcomes after 363 procedures
Lederman RJ, Mendelsohn FO, Santos RM, Phillips HR, Stack RS, Crowley JJ, Am Heart J, 1/1/2001
Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model
Kruse KR, Crowley JJ, Tanguay JF, Santos RM, Millare DS, Phillips HR, Zidar JP, Stack RS, Catheter Cardiovasc Interv, 1/1/1999
Kissing stents in the aortic bifurcation
Mendelsohn FO, Santos RM, Crowley JJ, Lederman RJ, Cobb FR, Phillips HR, Weissman NJ, Stack RS, Am Heart J, 1/1/1998
Progression of renal artery stenosis in patients undergoing cardiac catheterization
Crowley JJ, Santos RM, Peter RH, Puma JA, Schwab SJ, Phillips HR, Stack RS, Conlon PJ, Am Heart J, 1/1/1998
Join now to see all

Books/Book Chapters

Goldman's Cecil medicine
Chapter: Vascular disorders of the kidney
Page 783 - 788Dubose TD Jr, Santos RMEditors: Goldman L, Schafer AI.Elsevier/Saunders, Philadelphia, PAEdition 24th,2012
Cecil medicine
Chapter: Vascular disorders of the kidney
Page 891 - 897DuBose TD Jr, Santos RMEditors: Goldman L, Ausiello D.Saunders Elsevier, Philadelphia, PAEdition 23rd,2008

Abstracts/Posters

Influence of stent type on 30-day percutaneous coronary intervention readmissions.
Applegate RJ, Sacrinty MT, Green DR, Gandhi SK, Kutcher MA, Santos RM, Zhao DX, Cathet Cardiovasc Interv, 1/1/2014
Gender differences in vascular complications associated with transfemoral and transradial cardiac catheterization and PCI: a single-center experience.
Anderson J, Sacrinty M, Turner S, Gandhi S, Santos R, Kutcher M, Little W, Applegate R, J Am Coll Cardiol, 1/1/2013
Cost effectiveness of Everolimus-eluting compared to propensity score matched bare metal stenting: an analysis of a selected stent strategy.
Applegate RJ, Sacrinty M, Gandhi S, Kutcher M, Santos R, Little W, J Am Coll Cardiol, 1/1/2013
Peak troponin I greater than 5 times the 99th percentile after PCI does not define a high-risk group.
Butler M, Sacrinty M, Little W, Applegate R, Kutcher M, Santos R, Gandhi S, J Am Coll Cardiol, 1/16/2012
Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention.
Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W, Catheter Cardiovasc Interv, 1/1/2012
Cost-effectiveness analysis of propensity matched radial and femoral cardiac catheterization and coronary intervention.
Schafer P, Sacrinty MT, Smith JW, Little W, Gandhi S, Kutcher M, Santos R, Smith T, Cecile AC, Applegate R, J Am Coll Cardiol, 1/1/2012
Cost effectiveness of everolimus-eluting stents compared to propensity score matched bare metal stents in contemporary clinical practice.
Applegate RJ, Sacrinty MT, Gandhi SK, Kutcher MA, Santos RM, Smith TD, Little WC, J Am Coll Cardiol, 1/1/2012
Contrast use and acute kidney injury in contemporary clinical practice.
Applegate R, Sacrinty M, Allem J, Gandhi S, Kutcher M, Santos R, Smith T, Little W, J Am Coll Cardiol, 1/1/2012
Cost effectiveness of Everolimus-eluting stents compared to first generation drug-eluting stents in contemporary clinical practice.
Applegate R, Sacrinty M, Gandhi S, Kutcher M, Santos R, Smith T, Little W, J Am Coll Cardiol, 1/1/2012
Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: Effect of stent length and diameter.
Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ, J Am Coll Cardiol, 1/1/2011
Resource utilization for propensity matched radial and femoral catheterization and intervention.
Schafer PE, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Applegate RJ, J Am Coll cardiol, 1/1/2011
Cath Lab Utilization during Transition to the Radial Artery as Preferred Access: The Wake Forest Academic Medical Center Experience.
Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue, MR, Applegate RJ, J Am Coll Cardiol, 1/1/2011
Bleeding avoidance strategy: Transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest Academic Medical Center experience.
Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ, J Am Coll Cardiol, 1/1/2011
Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience.
Applegate RJ, Kutcher, MA, Little WC, Gandhi SK, Turner, SJ, Sacrinty, MT, Santos RM, J Am Coll Cardiol, 1/1/2011
Cost-effectiveness of "off-label" drug-eluting stent versus bare metal stent use.
Schafer P, Sacrinty M, Kutcher MA, Santos R, Gandhi SK, Little WC, Applegate RJ, J Am Coll Cardiol, 1/1/2010
Three-year comparison of drug-eluting versus bare metal stents.
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, J Am Coll Cardiol, 1/1/2009
Clinical outcomes of bare metal stents versus drug-eluting stents target vessel revascularization: evidence for a high-risk bare metal stent cohort.
Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, J Am Coll Cardiol, 1/1/2009
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC, J Am Coll Cardiol, 1/1/2009
Drug-eluting stent versus bare metal stent use in patients with chronic kidney disease.
Santos RM, Sacrinty MT, Kutcher MA, Gandhi SK, Little WC, Applegate RJ, J Am Coll Cardiol, 1/1/2009
Prognostic implications of vascular complications following PCI.
Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R, Catheter Cardiovasc Interv, 1/1/2009
Culprit vessel primary percutaneous coronary intervention for ST elevation myocardial infarction shorter door to balloon time.
Graham SH, Applegate RJ, Gandhi SK, Sacrinty MT, Baki TT, Santos RM, Little WC, Kutcher MA, J Am Coll Cardiol, 1/1/2008
Drug-eluting stents versus bare metal stents in saphenous vein grafts at 2 years.
Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, J Am Coll Cardiol, 1/1/2008
Drug-eluting stents for ST elevation myocardial infarction: evidence for benefit at two years.
Gandhi SK, Kay JD, Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Little WC, J Am Coll Cardiol, 1/1/2008
Prognostic implications of post percutaneous coronary intervention vascular complications.
Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, Am J Cardiol, 1/1/2008
Comparison of drug-eluting versus bare metal stents: timing of subacute thrombosis up to two years.
Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC, J Am Coll Cardiol, 1/1/2007
Join now to see all

Lectures

Top Ten Dieting Tips
Joslin Diabetes Center, Winston Salem, NC - 1/29/2014
ACS, 2012 Update
Winston-Salem, NC - 1/27/2014
The New Cathlab: Advanced Cardiac Procedures
Winston-Salem, NC - 1/13/2014
Peripheral Vascular Disease Overview
Winston-Salem, NC, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2015 - 1/1/2014
Coronary Physiology
Winston-Salem, NC, 2009, 2010, 2011, 2012, 2013, 2015 - 1/1/2014
Introduction to the Cardiac Catheterization Lab and Coronary Anatomy
Winston-Salem, NC, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2015 - 1/1/2014
Renal Artery Denervation
Asheville, NC - 1/10/2013
Health Fair
Clemmons United Methodist Church, Clemmons, NC - 1/9/2013
Refractory HTN and Renal Denervation
Winston-Salem, NC - 1/6/2013
Acute Coronary Syndromes
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC - 1/5/2013
Renal Artery Stenosis
Winston-Salem, NC - 1/1/2013
Novel Antiplatelet and Anticoagulant Agents
Wilkes Regional Medical Center, North Wilkesboro, NC - 1/20/2012
Chest Pain in Primary Care
Winston-Salem, NC - 1/17/2012
Chronic Stable Angina
Winston-Salem, NC - 1/15/2012
Hypertensive Emergencies
Winston-Salem, NC - 1/26/2011
The Thoracic Aorta for the General Internist
Winston-Salem, NC - 1/8/2011
Lowering Cholesterol the Natural Way
Winston-Salem, NC - 1/15/2010
Lowering Cholesterol
Winston-Salem, NC - 1/2/2008
Metabolic Syndrome and Cardiovascular Risk
Village Inn and Conference Center, Clemmons, NC - 1/2/2007
Review of Drug Eluting Stents
Winston-Salem, NC - 1/22/2006
Clinico-Path Conference
Winston-Salem, NC - 1/1/2006
Management of Peripheral Vascular Disease
Mt. Airy, NC - 1/27/2005
Treatment and Prevention of Coronary Artery Disease
Multiple Locations, 2005 - 1/25/2005
Lipid Management Post MI
Charlotte, NC - 1/25/2005
Clinical Research in the Practice Setting
1/23/2005
Join now to see all